Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Announcement under Regulation 30 (LODR)-Meeting Updates

 We would like to inform you that, with respect to Reg. 30 read with part A of Schedule III of SEBI (LODR) Reg., 2015 the Board of Directors at the meeting held on 17th June, 2018, inter alia transacted the following Business: 1.Appointment of Ms. Ami R. Shah as Additional Independent Director: Ms. Ami R. Shah (DIN: 08158605) has been appointed as an Additional Independent Director on the Board, subject to her appointment by the...
19-06-2018
Bigul

Announcement under Regulation 30 (LODR)-Newspaper Publication

 The newspaper advertisements published in both the English and Gujarati edition of Western Times regarding the publication of the audited financial results of the company for the financial year ended 31st March, 2018.
01-06-2018
Bigul

Results-Audited Financial Results For Quarter And Year Ended On 31.03.2018

 This is to inform you that Board of Directors at the meeting held today, i.e., 30th May, 2018, inter alia transacted the following business: 1. Approved, considered and taken on record the Audited Financial Results of the company for the quarter and year ended 31st March, 2018 along with Auditors'' Report of the Company. 2. Auditor's Report with unmodified opinion on Audited Financial Results for the quarter and year ended 31st March, 2018....
30-05-2018
Bigul

Annual report for Parmax Pharma Ltd. for FY-2018
30-05-2018
Bigul

BOARD MEETING DATED 30 MAY 2018

 INTIMATION OF BOARD MEETING WITH REGULATION 29 AND 33 OF SEBI LODR 2015
23-05-2018
Bigul

Certificate(S) Relating To The Transfer Of Shares Received During The Period From 1St OCTOBER, 2017 To 31ST MARCH, 2018

 certificate(s) relating to the transfer of Shares received during the period from 1st OCTOBER, 2017 to 31ST MARCH, 2018
23-04-2018
Bigul

Shareholding for the Period Ended March 31, 2018

 Parmax Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here
17-04-2018
Bigul

Statement Of Investor Complaints For The Quarter Ended March 2018

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- KEYUR DINESHBHAI VORADesignation :- Authorised Signatory
11-04-2018
Bigul

Compliances-Compliance Certificate For The Period Ended March 31, 2018

 pursuant to Regulation 7(3) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained by the company''s registrar and share transfer agent, viz. Purva Shareregistry (India) Private Limited which is SEBI approved Permanent Category-1 Registrar and Transfer Agent, registered with Securities...
05-04-2018
Bigul

Annual report for Parmax Pharma Ltd. for FY-2017
31-05-2017
Close

Let's Open Free Demat Account